Blueprint Genetics Overview

  • Founded
  • 2012
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 150
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $108M
Latest Deal Amount

Blueprint Genetics General Information

Description

Provider of genetic testing and diagnostics services designed to offer clinical interpretation for hereditary diseases. The company's services offer comprehensive diagnostics for all medical specialties thus supporting health care professionals around the world in finding suitable care for patients and families with rare inherited diseases, enabling healthcare providers to improve the lives of the patients.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Services
Other Industries
Laboratory Services (Healthcare)
Parent Company
Primary Office
  • Keilaranta 16 A-B
  • 02150 Espoo
  • Finland
+358 040 0000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Blueprint Genetics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 21-Jan-2020 $108M 000.00 00000 Completed Generating Revenue
8. Later Stage VC (Series D) 07-Jan-2020 00.000 000.00 000.00 Completed Generating Revenue
7. Later Stage VC 25-Apr-2019 Cancelled Generating Revenue
6. Later Stage VC (Series C) 20-Jul-2017 000.00 000.00 000.00 Completed Generating Revenue
5. Accelerator/Incubator 000.00 Completed Generating Revenue
4. Early Stage VC 16-Oct-2015 000.00 000.00 000.00 Completed Generating Revenue
3. Early Stage VC 29-Aug-2014 00.00 00.000 000.00 Completed Generating Revenue
2. Angel (individual) $1.26M $1.26M Completed Startup
1. Accelerator/Incubator Completed Startup
To view Blueprint Genetics’s complete valuation and funding history, request access »

Blueprint Genetics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference Series D 000,000 000.00 000.00 00 000.00 00.000
Ordinary 000,000 000.00 000.00 00 000.00 00.000
Ordinary 217,852 $19.93 $19.93 0x $19.93 5.49%
To view Blueprint Genetics’s complete cap table history, request access »

Blueprint Genetics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of genetic testing and diagnostics services designed to offer clinical interpretation for hereditary diseases.
Other Healthcare Services
Espoo, Finland
150 As of 2019
000.00
0000 0000-00-00
000000&0 000.00

00000000

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sin
0000000000 000000000
Cambridge, MA
000 As of 0000
00000
00 0000-00-00
00000000000

00000 00

ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse
0000000000000
Aliso Viejo, CA
000 As of 0000
00 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Blueprint Genetics Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Foundation Medicine Corporate Backed or Acquired Cambridge, MA 000 00000 00000000000
00000 00000000 Private Equity-Backed Aliso Viejo, CA 000 000000&0
00000000000 Formerly VC-backed Portland, OR 000 000.00 000000&0 000.00
00000000000 000000 Venture Capital-Backed Palo Alto, CA 000 00000 000000000 - 00000
0000000000 0000000 Corporation Burlington, NC 00000 00000000000
You’re viewing 5 of 7 competitors. Get the full list »

Blueprint Genetics Executive Team (17)

Name Title Board Seat Contact Info
Tommi Lehtonen Co-Founder & Chief Executive Officer
Samuel Myllykangas Ph.D Co-Founder & Chief Strategy Officer
Jessica Kim Manager, Client Services
Tero-Pekka Alastalo Ph.D Co-Founder, President & Co-Chief Medical Officer
Juha Koskenvuo Ph.D Co-Founder, Co-Chief Medical Officer & Laboratory Director
You’re viewing 5 of 17 executive team members. Get the full list »

Blueprint Genetics Board Members (9)

Name Representing Role Since
Ann-Christine Sundell Self Board Member 000 0000
Brock Siegel Ph.D Self Board Member 000 0000
Christian Leikert Creathor Venture Board Member 000 0000
Christoph Kausch Ph.D MTIP Board Member 000 0000
David Germonpré Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Blueprint Genetics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Blueprint Genetics Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Avohoidon Tutkimussäätiö PE/Buyout Minority 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0
Cota Capital Venture Capital Minority 000 0000 000000 0
Creathor Venture Venture Capital Minority 000 0000 000000 0
Inventure (Finland) Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »